TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion of cases with matched recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Adverse Event of Special Interest events (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with Serious Adverse Event (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Integration with existing clinical workflow
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost of care reduction for anastomotic leak patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Glycemic control by glycated hemoglobin (HbA1c) monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycemic control by Time-in-Range (TIR) monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to attain Cmax concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC0-8h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuronal Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Breakage of Electrode
Endpoint domain: Adverse events/effects
Primary endpoint: Minimum Residual Disease (MRD) Negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of periprosthetic joint infections
Endpoint domain: Adverse events/effects
Primary endpoint: change in spherical equivalent refractive error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Reached
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Viscoelastic Properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ankle-foot Dorsiflexion Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in IBS-SSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission clinical diagnosis of insomnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in insomnia severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative time to rescue analgesia requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bayley Scales of Infant Toddler Development, 4th Edition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in urinary anti-adhesion activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Objective Response (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardized Mini-Mental State Examination (SMMSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subjective assessments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Actimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion (development of IgG antibodies)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: anxious behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory Occlusion Pressure Muscle Index (PMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Complete ultrasound study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of molar distalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin concentration in prepared feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Parathyroid hormone related protein (PTHrP) concentration in prepared feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resolution of NASH/MASH and a ≥ 1 stage improvement in fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Amount of blood products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement of mixed urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Report of concussion in past year
Endpoint domain: Adverse events/effects
Primary endpoint: Report of lower extremity injury in past year
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of MPE and HA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammation of the synovial membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Gross Motor Function Measurement (GMFM-66)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of the Obsessive-Compulsive Scale: Y-BOCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in PHQ-9 Scores Among Patients with Obsessive-Compulsive Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychological Test Changes in Obsessive-Compulsive Disorder: WCST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sports injury anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Microbiome Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of transcranial magnetic stimulation in treatment of resistant major depression (Hamilton Rating Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of transcranial magnetic stimulation in treatment of resistant major depression (Clinical Global Impression Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD Checklist for the DSM-5 (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behavioral pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective olfactory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective symptoms and social/emotional consequences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of responders according to the ASRS-v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of food repertoire at sixth weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of food repertoire at 12th weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants developing postoperative nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants developing postoperative major complications
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting immediate adverse events after each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting solicited post-vaccination reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerance of FT-002
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Symptom Checklist Scale - 90 - R
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in APS antibody status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutralization antibody GMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody positivity testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement of lower urinary tract symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: AUClast of telmisartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Action Potential (AP) Latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Roeder Manipulative Aptitude Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ability to Recover Sense of Smell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bruininks-Oseretsky Test of Motor Proficiency-2 (BOT-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dunn Sensory Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of oocytes obtained at oocyte pick-up (OPU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Quality of embryos at the end of IVF treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Participants with Clinically Significant Laboratory Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of severity of the Metabolic Syndrome components
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: accuracy of PECARN guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of NICE guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual Cancer Burden (RCB) 0/I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hamilton anxiety rating scale (HAM-A) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time for platelets to rise from nadir to 75 x 10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Presence of furcation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Endothelium-Dependent Vasodilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Autophagic Flux Protein Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of dose-limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: mean uGAG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: discipline-specific performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Health Belief Model Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Baseline Self-Efficacy for Diabetes Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: grade 3 and 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: number of participants with neoantigen specific long peptide vaccine identified and generated
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of implant survival in nasal and temporal bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-implant complications using the Holgers' (grade 0-4)
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of Life with SF-36, SWLS and RSES
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Engagement in Personal Healthcare
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Enrolled Patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child Abuse and Neglect Awareness Scale (CANA-S)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent panel-reactive antibodies (PRAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of Recovery-40 (QoR-40) questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tumor regression ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants with at least 1 Episode of Hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Safety measured by CTCAE
Endpoint domain: Adverse events/effects
Primary endpoint: Magnetic Resonance Imaging (MRI) results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of significant clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in PPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Initial direction error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial direction error variance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Questionnaire Specific Response Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Difference of [18F]RoSMA-18-d6 uptake in the brain and spinal cord
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of adverse events - CTCAE
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events - ASTCT
Endpoint domain: Adverse events/effects
Primary endpoint: Immunological characterization of CL lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Metabolic profile of CL lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical parameters post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device-related complications (Clavien-Dindo grade III or higher)
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence rate of atrial arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left atrial end diastolic diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Block application time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Muscle strength and/or Muscle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antral follicle diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Antral follicle count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Follicle stimulating hormone (FSH) serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Dietary Pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cycloplegic Spherical Equivalent Refractive Error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast edema severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Recruitment to the target sample of 30 participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to group intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 3-year Progression Free Survival (PFS) rates
Endpoint domain: Mortality/survival
Primary endpoint: change in intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: PJP diagnosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Swelling/ Fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse Events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in phenylpropionic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fungal population levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the number of T cells that react to fungal antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Numeric Rating Scale (NRS-11) pain score during movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of LVOT-VTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plantar Pressure Distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean age at the hATTR-PN or CIAP diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women and men
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Proportion of patients with underweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta Numerical Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving PASI 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving sPGA 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving PASI 90 for Apremilast Non-Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of overall complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of leak (>5 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite rate of all-cause mortality, all stroke, systemic embolism, and major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Objective Response Rate (ORR) Based on Investigator Assessment (IA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of primary outcome events
Endpoint domain: Mortality/survival
Primary endpoint: cancer-related fatigue (CRF)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Time-normalized number of Investigator-confirmed HAE attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in pain level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensory processing measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aerosol-generating amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of fatigue symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: GluCEST imaging metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of annual DR screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in numeric rating scale (NRS) scores in pain diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater reliability of the 5 iAEs grading systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater reliability of the ICARUS Calculator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete grading (minutes) using the ICARUS Calculator
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ventilation/perfusion ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of conditions in the range of normal inspiratory effort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Burden Rate
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Rate of Activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Attention span
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Sequencing skill
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vocabulary development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Initiation for expression
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Non verbal communication
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improving the clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study Medication Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: CNS inflammatory effects
Endpoint domain: Adverse events/effects
Primary endpoint: Occlusal wear in natural antagonist enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Problematic Internet Use Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Self-Efficacy Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Electrical Activity of the Diaphragm (EAdi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Neuro-Mechanical Coupling (NMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuro-Ventilatory Efficiency (NVE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory rate (Breaths/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in donor specific antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes